GKSL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gujarat Kidney And Super Speciality Limited informed stock exchanges about the outcome of its board meeting held on March 19, 2026. The board approved the appointment of Mr. Dharmendra Bhaliya, a Practicing Company Secretary from Vadodara, as the Secretarial Auditor for FY 2025-26. It also appointed Mr. Siddharth Atulbhai Shah, a Chartered Accountant (FRN 157167W), as the Internal Auditor for FY 2025-26. Both professionals have relevant experience — about 5 years in corporate laws for the secretarial auditor and 7 years in assurance, internal audit, and forensic accounting for the internal auditor. The board also ratified actions taken in its February 14, 2026 meeting, which included approval of unaudited standalone and consolidated financial results for Q2 and H1 FY26 (quarter and half-year ended September 30, 2025). The filing appears to be a routine resubmission with corrected typographical errors.
This is a routine governance filing with no material impact on shareholders. The appointments are standard compliance requirements under the Companies Act and SEBI listing rules, and the financial results are simply being resubmitted with corrections.